ESSILORLUXOTTICA (1EL.MI) Stock Fundamental Analysis

BIT:1EL • FR0000121667

260.3 EUR
+9.4 (+3.75%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1EL. 1EL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While 1EL is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, 1EL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year 1EL was profitable.
  • In the past year 1EL had a positive cash flow from operations.
  • 1EL had positive earnings in each of the past 5 years.
  • 1EL had a positive operating cash flow in each of the past 5 years.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • 1EL's Return On Assets of 3.84% is in line compared to the rest of the industry. 1EL outperforms 55.56% of its industry peers.
  • 1EL's Return On Equity of 6.29% is in line compared to the rest of the industry. 1EL outperforms 47.62% of its industry peers.
  • With a Return On Invested Capital value of 5.39%, 1EL perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 1EL is significantly below the industry average of 9.98%.
  • The last Return On Invested Capital (5.39%) for 1EL is above the 3 year average (4.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROIC 5.39%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • 1EL has a better Profit Margin (8.74%) than 61.90% of its industry peers.
  • 1EL's Profit Margin has improved in the last couple of years.
  • 1EL has a Operating Margin (12.86%) which is in line with its industry peers.
  • 1EL's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 61.91%, 1EL is doing good in the industry, outperforming 63.49% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1EL has remained more or less at the same level.
Industry RankSector Rank
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1EL is destroying value.
  • The number of shares outstanding for 1EL has been increased compared to 1 year ago.
  • The number of shares outstanding for 1EL has been increased compared to 5 years ago.
  • The debt/assets ratio for 1EL is higher compared to a year ago.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.97 indicates that 1EL is not in any danger for bankruptcy at the moment.
  • 1EL has a Altman-Z score of 3.97. This is in the better half of the industry: 1EL outperforms 69.84% of its industry peers.
  • 1EL has a debt to FCF ratio of 4.18. This is a neutral value as 1EL would need 4.18 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.18, 1EL is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
  • 1EL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • 1EL has a better Debt to Equity ratio (0.25) than 63.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Altman-Z 3.97
ROIC/WACC0.69
WACC7.8%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that 1EL may have some problems paying its short term obligations.
  • 1EL has a worse Current ratio (0.97) than 80.95% of its industry peers.
  • A Quick Ratio of 0.67 indicates that 1EL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.67, 1EL is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.67
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.00% over the past year.
  • Measured over the past years, 1EL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.01% on average per year.
  • 1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.45%.
  • 1EL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.80% yearly.
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%

3.2 Future

  • Based on estimates for the next years, 1EL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.60% on average per year.
  • 1EL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.56% yearly.
EPS Next Y5.69%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
EPS Next 5Y9.6%
Revenue Next Year5.99%
Revenue Next 2Y6.94%
Revenue Next 3Y7.45%
Revenue Next 5Y7.56%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 37.89, which means the current valuation is very expensive for 1EL.
  • The rest of the industry has a similar Price/Earnings ratio as 1EL.
  • 1EL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.67.
  • 1EL is valuated quite expensively with a Price/Forward Earnings ratio of 32.38.
  • Based on the Price/Forward Earnings ratio, 1EL is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, 1EL is valued at the same level.
Industry RankSector Rank
PE 37.89
Fwd PE 32.38
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1EL.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1EL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 35.85
EV/EBITDA 19.83
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EL does not grow enough to justify the current Price/Earnings ratio.
  • 1EL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.66
PEG (5Y)2.37
EPS Next 2Y8.8%
EPS Next 3Y10.77%

6

5. Dividend

5.1 Amount

  • 1EL has a Yearly Dividend Yield of 1.53%. Purely for dividend investing, there may be better candidates out there.
  • 1EL's Dividend Yield is a higher than the industry average which is at 0.97.
  • 1EL's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

  • The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 22.97% of the earnings are spent on dividend by 1EL. This is a low number and sustainable payout ratio.
  • The dividend of 1EL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.97%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

ESSILORLUXOTTICA

BIT:1EL (2/12/2026, 7:00:00 PM)

260.3

+9.4 (+3.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-16
Earnings (Next)02-11
Inst Owners28.97%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap120.56B
Revenue(TTM)27.24B
Net Income(TTM)2.38B
Analysts81.94
Price Target337.12 (29.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP22.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.63%
PT rev (3m)7.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.45%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 37.89
Fwd PE 32.38
P/S 4.43
P/FCF 35.85
P/OCF 24.53
P/B 3.19
P/tB N/A
EV/EBITDA 19.83
EPS(TTM)6.87
EY2.64%
EPS(NY)8.04
Fwd EY3.09%
FCF(TTM)7.26
FCFY2.79%
OCF(TTM)10.61
OCFY4.08%
SpS58.82
BVpS81.67
TBVpS-5.08
PEG (NY)6.66
PEG (5Y)2.37
Graham Number112.36
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROCE 6.93%
ROIC 5.39%
ROICexc 5.71%
ROICexgc 35.85%
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
FCFM 12.34%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
ROICexc(3y)5.06%
ROICexc(5y)3.96%
ROICexgc(3y)34.05%
ROICexgc(5y)28.3%
ROCE(3y)6.22%
ROCE(5y)4.81%
ROICexgc growth 3Y0.01%
ROICexgc growth 5Y9.27%
ROICexc growth 3Y12.06%
ROICexc growth 5Y11.05%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Debt/EBITDA 1.41
Cap/Depr 49.38%
Cap/Sales 5.69%
Interest Coverage 250
Cash Conversion 73.95%
Profit Quality 141.24%
Current Ratio 0.97
Quick Ratio 0.67
Altman-Z 3.97
F-Score7
WACC7.8%
ROIC/WACC0.69
Cap/Depr(3y)51.19%
Cap/Depr(5y)45.17%
Cap/Sales(3y)6.06%
Cap/Sales(5y)5.58%
Profit Quality(3y)145.59%
Profit Quality(5y)677.55%
High Growth Momentum
Growth
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
EPS Next Y5.69%
EPS Next 2Y8.8%
EPS Next 3Y10.77%
EPS Next 5Y9.6%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%
Revenue Next Year5.99%
Revenue Next 2Y6.94%
Revenue Next 3Y7.45%
Revenue Next 5Y7.56%
EBIT growth 1Y6.6%
EBIT growth 3Y15.34%
EBIT growth 5Y15.84%
EBIT Next Year56.89%
EBIT Next 3Y23.64%
EBIT Next 5Y17.35%
FCF growth 1Y3.16%
FCF growth 3Y-1.57%
FCF growth 5Y6.95%
OCF growth 1Y2.06%
OCF growth 3Y2.36%
OCF growth 5Y8.12%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1EL.MI.


Can you provide the valuation status for ESSILORLUXOTTICA?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 6 / 10.


What is the financial health of ESSILORLUXOTTICA (1EL.MI) stock?

The financial health rating of ESSILORLUXOTTICA (1EL.MI) is 3 / 10.


Can you provide the expected EPS growth for 1EL stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 5.69% in the next year.